OPCH•McKesson’s FY27 second-quarter adjusted earnings per diluted share rose 18% year over year to $11.68. The company raised its FY27 adjusted EPS guidance to $45.60–$46.40 and agreed to invest about $1.4 billion for an approximately 49% stake in Option Care Health.
McKesson’s FY27 second-quarter adjusted earnings per diluted share climbed 18% year over year to $11.68. The company raised its FY27 adjusted EPS guidance to $45.60–$46.40 from $44.20–$45.
Under a definitive agreement signed October 5, McKesson will invest approximately $1.4 billion for an approximately 49% minority interest in Option Care Health. McKesson’s November 2 acquisition of Precision Medicine Group expanded its capabilities in oncology, multispecialty and biopharma services.
